A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.

This study is ongoing, but not recruiting participants.

Study NCT00905489 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: May 6, 2009 Last Updated: February 8, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2012 (Final data collection date for primary outcome measure)